Increased evidence indicates that decreased IL-10 and TGF-β1 levels are accompanied by the onset of acute coronary syndrome and that high concentrations of IL-10 and TGF-β1 could improve the prognosis of patients with coronary artery disease [5]–[11]. This evidence concerns the gene TGFB1 and acute coronary syndrome.